The Regenerative Medicine Research Institute aims to discover and improve current therapies and diagnoses in order to improve the quality of life for people suffering from injuries and chronic diseases.
The Universitat Internacional de Catalunya set up the Regenerative Medicine Research Institute in 2014, with the aim of expanding the knowledge and research of adult stem cells for tissue regeneration. The RMRI was conceived as a research centre to develop new strategies and therapies to help restore damaged tissues. For this purpose, the RMRI revolved around a new type of pluripotent stem cell found in the dental pulp. These cells were found in the third molars of humans, and were shown to possess pluripotent phenotypes that can mimic those of induced pluripotent stem cells and embryonic stem cells, while avoiding safety and ethical issues.
The present day
The Regenerative Medicine Research Institute is expanding in terms of research and qualified researchers. In order to potentiate the clinical applications of the DPPSC, in 2016, the Regenerative Medicine Research Institute started researching the design and development of biomaterials for regenerative medicine and tissue engineering. The aim is to combine these biomaterials with the DPPSC and to design biomaterials in such a way to allow the behaviour of the cells to be capriciously controlled. This interesting approach relies on the tuning of the physical and chemical properties.
The future (our vision)
The Regenerative Medicine Research Institute aims to become a leading world expert with international recognition in the field of regenerative medicine and tissue engineering, based on basic research on the clinical challenges that still need to be tackled.